People: Osiris Therapeutics Inc (OSIR.OQ)
6 Dec 2013
Dr. Hans Klingemann, M.D., Ph.D. has been appointed as the Independent Director of Osiris Therapeutics Inc. Before coming to Boston, Dr. Klingemann served as Director of Bone Marrow Transplant and Cell Therapy at Rush University Medical Center, and founding Director of the Sramek Center for Cell Engineering in Chicago, Illinois. He has worked as a physician, scientist, educator and administrator in leadership positions for over twenty years at various academic medical centers in Europe and North America and has authored over 170 scientific and medical papers. Recently he was appointed Chief Medical and Scientific Officer of Conkwest Inc. the cell therapy company he founded in 2002. Dr. Klingemann received his M.D. from the University of Würzburg Medical School, Germany, and his Ph.D. from the University of Marburg, Germany. Dr. Klingemann serves as a member on the Audit, Compensation and Nominating Committee.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|